Astragaloside IV alleviates inflammation and improves myocardial metabolism in heart failure mice with preserved ejection fraction

BackgroundHeart failure with preserved ejection fraction (HFpEF) has grown to become the dominant form of heart failure worldwide. However, no unequivocally effective treatment for HFpEF has been identified in clinical trials. In this study, we report that Astragaloside IV (AS-IV) can be used to tre...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Xiao Wang, Xinting Chen, Yuting Wang, Xinyu He, Lan Li, Xiaodan Wang, Yuting Huang, Guanwei Fan, Jingyu Ni
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2024-11-01
Colecção:	Frontiers in Pharmacology
Assuntos:	HFpEF astragaloside IV inflammation metabolism mitochondria
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1467132/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!